November 4, 2010

An investigative treatment for hepatitis C got strong results in patients who had failed previous...

September 27, 2010

The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...

September 7, 2010

Bristol-Myers Squibb will acquire Seattle-based biotech ZymoGenetics, Bristol said Wednesday....

August 8, 2010

An investigational drug in late-stage clinical trials increased the cure rate in patients with hepatitis...

June 8, 2010

German drug maker Bayer HealthCare said a 16-year follow-up to a clinical trial of one...

June 2, 2010

German drug maker Bayer HealthCare Pharmaceuticals has created an iPhone application that it called the...

May 25, 2010

A majority of people taking an investigational treatment for hepatitis C were cured after taking...

May 23, 2010

Swiss biotech company Biogen Idec and U.S. drug maker Abbott have begun enrolling patients in...